USD 27.14
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 255.9 Million | 291.6 Million | 243.4 Million | 111 Million | 300.9 Million | 114.66 Million |
Net Income | 530.8 Million | 251 Million | 565.4 Million | 509.5 Million | 114.5 Million | 234.67 Million |
Depreciation & Amortization | 18 Million | 18.2 Million | 19.5 Million | 19.2 Million | 10.6 Million | 5.9 Million |
Deferred income taxes | - | -39.5 Million | -29.6 Million | -26.9 Million | -25.2 Million | - |
Stock-based compensation | 43.9 Million | 39.5 Million | 29.6 Million | 26.9 Million | 25.2 Million | 27 Million |
Change in working capital | -106.4 Million | -217.7 Million | -59.9 Million | 51.8 Million | 23.3 Million | - |
Other non-cash items | -483 Million | 240.1 Million | -281.6 Million | -469.5 Million | 152.5 Million | -120.01 Million |
Investing Cash Flow | 71.5 Million | 130.8 Million | 45.5 Million | 64.7 Million | -74 Million | 7.7 Million |
Investments in PPE | -9.5 Million | -11.2 Million | -7.8 Million | -10.8 Million | -10.1 Million | -5.2 Million |
Acquisitions | 49.5 Million | 200.8 Million | 30.9 Million | 34.9 Million | -37 Million | 12.9 Million |
Investment purchases | - | -1.75 Billion | -4.63 Billion | -3.91 Billion | -3.08 Billion | -3.87 Billion |
Sales/Maturities of investments | - | 2.12 Billion | 4.91 Billion | 3.91 Billion | 2.96 Billion | 3.48 Billion |
Other Investing Activities | 25.2 Million | -431.25 Million | -254.7 Million | 37.28 Million | 97.59 Million | 387.65 Million |
Financing Cash Flow | -282.5 Million | -476.7 Million | 111.3 Million | -653.3 Million | 471.2 Million | -133.1 Million |
Debt repayment | -59.1 Million | -201.4 Million | -115.6 Million | -502.4 Million | -146.3 Million | -2.15 Billion |
Dividends payments | -223.4 Million | -236.4 Million | -165.7 Million | -150.9 Million | -142.8 Million | -88.3 Million |
Common Stock Repurchased | - | -38.9 Million | -20.9 Million | - | -40.3 Million | -49.3 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 413.5 Million | - | 800.6 Million | 2.15 Billion |
Accounts receivables | -88.7 Million | -14.79 Million | -42.68 Million | -48.84 Million | 31.7 Million | - |
Accounts payables | - | -242.83 Million | -35.98 Million | 120.3 Million | - | - |
Inventory | - | - | - | 0.72 | - | - |
Other working capital | -88.7 Million | 39.93 Million | 18.76 Million | -19.66 Million | -8.4 Million | - |
Cash at beginning of period | 957.5 Million | 991.8 Million | 581.2 Million | 1.08 Billion | 354 Million | 520.7 Million |
Cash at end of period | 990 Million | 957.5 Million | 991.8 Million | 581.2 Million | 1.08 Billion | 354 Million |
Capital Expenditure | -9.5 Million | -11.2 Million | -7.8 Million | -10.8 Million | -10.1 Million | -5.2 Million |
Effect of forex changes on cash | -12.4 Million | 20 Million | 10.4 Million | -28.1 Million | 34.8 Million | -13.2 Million |
Net cash flow / Change in cash | 32.5 Million | -34.3 Million | 410.6 Million | -505.7 Million | 732.9 Million | -166.7 Million |
Free Cash Flow | 246.4 Million | 280.4 Million | 235.6 Million | 100.2 Million | 290.8 Million | 109.46 Million |
Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 530.8 Million | 311.53 Million | 269.06 Million | 232.47 Million | 251 Million | 39.39 Million |
Depreciation & Amortization | 18 Million | 10.98 Million | 11.34 Million | 12.7 Million | 18.2 Million | 8.81 Million |
Deferred income taxes | - | - | - | - | -39.5 Million | - |
Stock-based compensation | 43.9 Million | - | - | - | 39.5 Million | - |
Change in working capital | -106.4 Million | 32.44 Million | -161.12 Million | 24.17 Million | -217.7 Million | -255 Million |
Other non-cash items | -483 Million | -684.04 Million | 61.83 Million | -79.54 Million | 240.1 Million | 482.89 Million |
Investing Cash Flow | 71.5 Million | 732.26 Million | -6.34 Million | 312.39 Million | 130.8 Million | 200.32 Million |
Investments in PPE | -9.5 Million | -6.81 Million | -5 Million | -9.74 Million | -11.2 Million | -3.68 Million |
Acquisitions | 49.5 Million | 62.48 Million | -1.00 | 256.27 Million | 200.8 Million | -7.81 Million |
Investment purchases | - | -787.54 Million | -1.34 Billion | -934.84 Million | -1.75 Billion | -739.01 Million |
Sales/Maturities of investments | - | 1.46 Billion | 1.3 Billion | 1.01 Billion | 2.12 Billion | 1 Billion |
Other Investing Activities | 25.2 Million | -2.77 Million | 41.1 Million | -9.74 Million | -431.25 Million | -56.8 Million |
Financing Cash Flow | -282.5 Million | -99.09 Million | -248.81 Million | -293.4 Million | -476.7 Million | -266.5 Million |
Debt repayment | -59.1 Million | - | -61.83 Million | -196.95 Million | -201.4 Million | -38.94 Million |
Dividends payments | -223.4 Million | -93.28 Million | -182.34 Million | -88.79 Million | -236.4 Million | -183.47 Million |
Common Stock Repurchased | - | - | - | - | -38.9 Million | -43.41 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -5.8 Million | -4.63 Million | -7.64 Million | - | -669.6 Thousand |
Accounts receivables | - | -82.17 Million | -28.78 Million | -87.81 Million | -14.79 Million | 66.06 Million |
Accounts payables | - | 114.61 Million | -132.33 Million | 111.98 Million | -242.83 Million | -321.07 Million |
Inventory | - | - | - | - | - | - |
Other working capital | -88.7 Million | - | - | - | 39.93 Million | - |
Cash at beginning of period | 957.5 Million | 865.37 Million | 1.18 Billion | 961.99 Million | 991.8 Million | 1.3 Billion |
Cash at end of period | 990 Million | 1.24 Billion | 865.37 Million | 1.18 Billion | 957.5 Million | 961.99 Million |
Capital Expenditure | -9.5 Million | -6.81 Million | -5 Million | -9.74 Million | -11.2 Million | -3.68 Million |
Effect of forex changes on cash | -12.4 Million | - | -1.00 | 11.32 Million | 20 Million | 1.00 |
Net cash flow / Change in cash | 32.5 Million | 384.29 Million | -315.5 Million | 218.89 Million | -34.3 Million | -340.53 Million |
Free Cash Flow | 246.4 Million | -325.42 Million | -7.68 Million | 178.82 Million | 280.4 Million | -223.2 Thousand |
4951
4300
8022
EXS
4763
MED